SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 147 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 5.41 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $82,286 | +20.1% | 3,560 | +36.5% | 0.00% | – |
| Q2 2023 | $68,505 | +45.7% | 2,609 | +42.8% | 0.00% | – |
| Q1 2023 | $47,010 | -4.1% | 1,827 | -2.9% | 0.00% | – |
| Q4 2022 | $49,040 | -15.4% | 1,881 | -8.8% | 0.00% | – |
| Q3 2022 | $58,000 | +61.1% | 2,063 | +38.7% | 0.00% | – |
| Q2 2022 | $36,000 | -58.1% | 1,487 | -3.3% | 0.00% | – |
| Q1 2022 | $86,000 | -9.5% | 1,538 | -0.1% | 0.00% | – |
| Q4 2021 | $95,000 | +86.3% | 1,540 | +93.7% | 0.00% | – |
| Q3 2021 | $51,000 | +142.9% | 795 | +213.0% | 0.00% | – |
| Q2 2021 | $21,000 | +10.5% | 254 | 0.0% | 0.00% | – |
| Q1 2021 | $19,000 | – | 254 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 3,081,307 | $71,239,818 | 7.97% |
| Finepoint Capital LP | 556,928 | $12,876,175 | 6.41% |
| M28 Capital Management LP | 197,700 | $4,570,824 | 5.24% |
| Boxer Capital, LLC | 3,421,541 | $79,106,028 | 4.21% |
| Deep Track Capital, LP | 3,546,435 | $81,993,577 | 3.16% |
| EcoR1 Capital, LLC | 3,460,208 | $80,000,009 | 2.70% |
| Orbimed Advisors | 3,968,588 | $91,753,755 | 1.95% |
| Artal Group S.A. | 1,816,620 | $42,000 | 1.80% |
| SPHERA FUNDS MANAGEMENT LTD. | 319,911 | $7,396,342 | 1.35% |
| Perceptive Advisors | 1,520,416 | $35,152,017 | 1.17% |